APO Research
Talk to an analyst

APO RESEARCH · REPORT

Perfluorocarbon-based Ultrasound Contrast Agents

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Perfluorocarbon-based Ultrasound Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025199 pages

Choose your research edition.

Industry ResearchPerfluorocarbon-based Ultrasound Contrast Agents Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Perfluorocarbon-based Ultrasound Contrast Agents Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Perfluorocarbon-based Ultrasound Contrast Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Perfluorocarbon-based Ultrasound Contrast Agents Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Perfluorocarbon-based Ultrasound Contrast Agents Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Perfluorocarbon-based Ultrasound Contrast Agents market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Perfluorocarbon-based Ultrasound Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Perfluorocarbon-based Ultrasound Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Perfluorocarbon-based Ultrasound Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Perfluorocarbon-based Ultrasound Contrast Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Perfluorocarbon-based Ultrasound Contrast Agents include Bracco, GE Healthcare, ImaRx Therapeutics, Lantheus Medical Imaging, Microvascular Therapeutics, Feiruida Medical, Fuman Group, Lizhuo Pharmaceutical and Qi-hui Biopharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Perfluorocarbon-based Ultrasound Contrast Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Perfluorocarbon-based Ultrasound Contrast Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Perfluorocarbon-based Ultrasound Contrast Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Perfluorocarbon-based Ultrasound Contrast Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Perfluorocarbon-based Ultrasound Contrast Agents Segment by Company

Bracco

GE Healthcare

ImaRx Therapeutics

Lantheus Medical Imaging

Microvascular Therapeutics

Feiruida Medical

Fuman Group

Lizhuo Pharmaceutical

Qi-hui Biopharmaceutical

SUNΛ Med-Engineering

Perfluorocarbon-based Ultrasound Contrast Agents Segment by Type

Perfluorobutane

Perfluoropropane

Sulfur Hexafluoride

Others

Perfluorocarbon-based Ultrasound Contrast Agents Segment by Application

Liver Ultrasonography

Cardiac Ultrasonography

Angiographic Ultrasonography

Others

Perfluorocarbon-based Ultrasound Contrast Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Perfluorocarbon-based Ultrasound Contrast Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Perfluorocarbon-based Ultrasound Contrast Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Perfluorocarbon-based Ultrasound Contrast Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Perfluorocarbon-based Ultrasound Contrast Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Perfluorocarbon-based Ultrasound Contrast Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Perfluorocarbon-based Ultrasound Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Perfluorocarbon-based Ultrasound Contrast Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Perfluorocarbon-based Ultrasound Contrast Agents Industry Trends Table 2. Perfluorocarbon-based Ultrasound Contrast Agents Industry Drivers Table 3. Perfluorocarbon-based Ultrasound Contrast Agents Industry Opportunities and Challenges Table 4. Perfluorocarbon-based Ultrasound Contrast Agents Industry Restraints Table 5. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Manufacturers Table 9. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Perfluorocarbon-based Ultrasound Contrast Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Perfluorocarbon-based Ultrasound Contrast Agents Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Perfluorocarbon-based Ultrasound Contrast Agents Manufacturers, Product Type & Application Table 13. Global Perfluorocarbon-based Ultrasound Contrast Agents Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Perfluorocarbon-based Ultrasound Contrast Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Perfluorobutane Table 17. Major Manufacturers of Perfluoropropane Table 18. Major Manufacturers of Sulfur Hexafluoride Table 19. Major Manufacturers of Others Table 20. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2026) & (Units) Table 22. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2027-2032) & (Units) Table 23. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2021-2026) Table 24. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2027-2032) Table 25. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 26. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021-2026) & (Units) Table 27. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2027-2032) & (Units) Table 28. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type (2021-2026) Table 29. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Liver Ultrasonography Table 31. Major Manufacturers of Cardiac Ultrasonography Table 32. Major Manufacturers of Angiographic Ultrasonography Table 33. Major Manufacturers of Others Table 34. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application 2021 VS 2025 VS 2032 (Units) Table 35. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2026) & (Units) Table 36. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2027-2032) & (Units) Table 37. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2021-2026) Table 38. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2027-2032) Table 39. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 40. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021-2026) & (Units) Table 41. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2027-2032) & (Units) Table 42. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application (2021-2026) Table 43. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application (2027-2032) Table 44. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 45. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2021-2026) & (Units) Table 46. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Region (2021-2026) Table 47. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Forecasted by Region (2027-2032) & (Units) Table 48. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 50. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026) & (Units) Table 51. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2027-2032) & (Units) Table 52. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 53. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026) & (Units) Table 54. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2027-2032) & (Units) Table 55. Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 56. Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026) & (Units) Table 57. Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2027-2032) & (Units) Table 58. South America, Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 59. South America, Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2026) & (Units) Table 60. South America, Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2027-2032) & (Units) Table 61. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Region (2021-2026) Table 65. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Region (2027-2032) Table 66. Bracco Company Information Table 67. Bracco Business Overview Table 68. Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 70. Bracco Recent Development Table 71. GE Healthcare Company Information Table 72. GE Healthcare Business Overview Table 73. GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 75. GE Healthcare Recent Development Table 76. ImaRx Therapeutics Company Information Table 77. ImaRx Therapeutics Business Overview Table 78. ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 80. ImaRx Therapeutics Recent Development Table 81. Lantheus Medical Imaging Company Information Table 82. Lantheus Medical Imaging Business Overview Table 83. Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 85. Lantheus Medical Imaging Recent Development Table 86. Microvascular Therapeutics Company Information Table 87. Microvascular Therapeutics Business Overview Table 88. Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 90. Microvascular Therapeutics Recent Development Table 91. Feiruida Medical Company Information Table 92. Feiruida Medical Business Overview Table 93. Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 95. Feiruida Medical Recent Development Table 96. Fuman Group Company Information Table 97. Fuman Group Business Overview Table 98. Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 100. Fuman Group Recent Development Table 101. Lizhuo Pharmaceutical Company Information Table 102. Lizhuo Pharmaceutical Business Overview Table 103. Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 105. Lizhuo Pharmaceutical Recent Development Table 106. Qi-hui Biopharmaceutical Company Information Table 107. Qi-hui Biopharmaceutical Business Overview Table 108. Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 110. Qi-hui Biopharmaceutical Recent Development Table 111. SUNΛ Med-Engineering Company Information Table 112. SUNΛ Med-Engineering Business Overview Table 113. SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio Table 115. SUNΛ Med-Engineering Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Perfluorocarbon-based Ultrasound Contrast Agents Distributors List Table 119. Perfluorocarbon-based Ultrasound Contrast Agents Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Perfluorocarbon-based Ultrasound Contrast Agents Product Image Figure 2. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales (2021-2032) & (Units) Figure 5. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Perfluorocarbon-based Ultrasound Contrast Agents Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Perfluorobutane Image Figure 9. Perfluoropropane Image Figure 10. Sulfur Hexafluoride Image Figure 11. Others Image Figure 12. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2021-2032) Figure 15. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 16. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type (2021-2032) Figure 18. Liver Ultrasonography Image Figure 19. Cardiac Ultrasonography Image Figure 20. Angiographic Ultrasonography Image Figure 21. Others Image Figure 22. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2021-2032) Figure 25. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 26. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application (2021-2032) Figure 28. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 29. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country (2021-2032) Figure 30. U.S. Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 31. Canada Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 32. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 33. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 34. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country (2021-2032) Figure 35. Germany Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 36. France Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 37. U.K. Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 38. Italy Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 39. Netherlands Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 40. Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 41. Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country (2021-2032) Figure 42. China Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 43. Japan Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 44. South Korea Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 45. Southeast Asia Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 46. India Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 47. Australia Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 48. South America, Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 49. South America, Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Country (2021-2032) Figure 50. Brazil Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 51. South Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 52. Saudi Arabia Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 53. Turkey Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 54. Argentina Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 55. UAE Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 56. Egypt Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 57. Chile Perfluorocarbon-based Ultrasound Contrast Agents Sales and Growth Rate (2021-2032) & (Units) Figure 58. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Figure 61. North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Figure 63. Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Perfluorocarbon-based Ultrasound Contrast Agents Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Perfluorocarbon-based Ultrasound Contrast Agents Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Perfluorobutane
  • Perfluoropropane
  • Sulfur Hexafluoride
  • Others
Applications
  • Liver Ultrasonography
  • Cardiac Ultrasonography
  • Angiographic Ultrasonography
  • Others
Companies covered
  • Bracco
  • GE Healthcare
  • ImaRx Therapeutics
  • Lantheus Medical Imaging
  • Microvascular Therapeutics
  • Feiruida Medical
  • Fuman Group
  • Lizhuo Pharmaceutical
  • Qi-hui Biopharmaceutical
  • SUNΛ Med-Engineering

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Dynamics
  1. 2.1 Perfluorocarbon-based Ultrasound Contrast Agents Industry Trends
  2. 2.2 Perfluorocarbon-based Ultrasound Contrast Agents Industry Drivers
  3. 2.3 Perfluorocarbon-based Ultrasound Contrast Agents Industry Opportunities and Challenges
  4. 2.4 Perfluorocarbon-based Ultrasound Contrast Agents Industry Restraints
3 Perfluorocarbon-based Ultrasound Contrast Agents Market by Manufacturers
  1. 3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Manufacturers (2021-2026)
  3. 3.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Perfluorocarbon-based Ultrasound Contrast Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Perfluorocarbon-based Ultrasound Contrast Agents Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Perfluorocarbon-based Ultrasound Contrast Agents Manufacturers, Product Type & Application
  7. 3.7 Global Perfluorocarbon-based Ultrasound Contrast Agents Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Perfluorocarbon-based Ultrasound Contrast Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Perfluorocarbon-based Ultrasound Contrast Agents Tier 1, Tier 2, and Tier 3
4 Perfluorocarbon-based Ultrasound Contrast Agents Market by Type
  1. 4.1 Perfluorocarbon-based Ultrasound Contrast Agents Type Introduction
  2. 4.1.1 Perfluorobutane
  3. 4.1.2 Perfluoropropane
  4. 4.1.3 Sulfur Hexafluoride
  5. 4.1.4 Others
  6. 4.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type
  7. 4.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Type (2021-2032)
  9. 4.2.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Type (2021-2032)
  10. 4.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type
  11. 4.3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type (2021-2032)
  13. 4.3.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type (2021-2032)
5 Perfluorocarbon-based Ultrasound Contrast Agents Market by Application
  1. 5.1 Perfluorocarbon-based Ultrasound Contrast Agents Application Introduction
  2. 5.1.1 Liver Ultrasonography
  3. 5.1.2 Cardiac Ultrasonography
  4. 5.1.3 Angiographic Ultrasonography
  5. 5.1.4 Others
  6. 5.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application
  7. 5.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Application (2021-2032)
  9. 5.2.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Market Share by Application (2021-2032)
  10. 5.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application
  11. 5.3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Application (2021-2032)
  13. 5.3.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application (2021-2032)
6 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region
  1. 6.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales by Region (2021-2026)
  4. 6.2.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region
  1. 7.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region
  2. 7.1.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2021-2026)
  4. 7.1.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Region (2027-2032)
  5. 7.1.4 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032)
  8. 7.2.2 North America Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032)
  11. 7.3.2 Europe Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Perfluorocarbon-based Ultrasound Contrast Agents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Bracco
  2. 8.1.1 Bracco Company Information
  3. 8.1.2 Bracco Business Overview
  4. 8.1.3 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  6. 8.1.5 Bracco Recent Developments
  7. 8.2 GE Healthcare
  8. 8.2.1 GE Healthcare Company Information
  9. 8.2.2 GE Healthcare Business Overview
  10. 8.2.3 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  12. 8.2.5 GE Healthcare Recent Developments
  13. 8.3 ImaRx Therapeutics
  14. 8.3.1 ImaRx Therapeutics Company Information
  15. 8.3.2 ImaRx Therapeutics Business Overview
  16. 8.3.3 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  18. 8.3.5 ImaRx Therapeutics Recent Developments
  19. 8.4 Lantheus Medical Imaging
  20. 8.4.1 Lantheus Medical Imaging Company Information
  21. 8.4.2 Lantheus Medical Imaging Business Overview
  22. 8.4.3 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  24. 8.4.5 Lantheus Medical Imaging Recent Developments
  25. 8.5 Microvascular Therapeutics
  26. 8.5.1 Microvascular Therapeutics Company Information
  27. 8.5.2 Microvascular Therapeutics Business Overview
  28. 8.5.3 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  30. 8.5.5 Microvascular Therapeutics Recent Developments
  31. 8.6 Feiruida Medical
  32. 8.6.1 Feiruida Medical Company Information
  33. 8.6.2 Feiruida Medical Business Overview
  34. 8.6.3 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  36. 8.6.5 Feiruida Medical Recent Developments
  37. 8.7 Fuman Group
  38. 8.7.1 Fuman Group Company Information
  39. 8.7.2 Fuman Group Business Overview
  40. 8.7.3 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  42. 8.7.5 Fuman Group Recent Developments
  43. 8.8 Lizhuo Pharmaceutical
  44. 8.8.1 Lizhuo Pharmaceutical Company Information
  45. 8.8.2 Lizhuo Pharmaceutical Business Overview
  46. 8.8.3 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  48. 8.8.5 Lizhuo Pharmaceutical Recent Developments
  49. 8.9 Qi-hui Biopharmaceutical
  50. 8.9.1 Qi-hui Biopharmaceutical Company Information
  51. 8.9.2 Qi-hui Biopharmaceutical Business Overview
  52. 8.9.3 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  54. 8.9.5 Qi-hui Biopharmaceutical Recent Developments
  55. 8.10 SUNΛ Med-Engineering
  56. 8.10.1 SUNΛ Med-Engineering Company Information
  57. 8.10.2 SUNΛ Med-Engineering Business Overview
  58. 8.10.3 SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product Portfolio
  60. 8.10.5 SUNΛ Med-Engineering Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Perfluorocarbon-based Ultrasound Contrast Agents Value Chain Analysis
  2. 9.1.1 Perfluorocarbon-based Ultrasound Contrast Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Perfluorocarbon-based Ultrasound Contrast Agents Production Mode & Process
  6. 9.2 Perfluorocarbon-based Ultrasound Contrast Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Perfluorocarbon-based Ultrasound Contrast Agents Distributors
  9. 9.2.3 Perfluorocarbon-based Ultrasound Contrast Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst